SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

4174 (4174) News

Follow 4174 (4174) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 4174 Asset market Sector Markets 90 days 3 Updated Nov 16, 2026, 08:12 AM UTC Open live news feed
M OBI Pharma Gets $30M Upfront in Novartis ADC Collaboration OBI Pharma will receive $30 million upfront and is eligible for development, regulatory and commercial milestones that could bring total deal value to more than $2 billion, plus tiered royalties. MNA | Nov 16, 2026, 08:12 AM UTC M OBI Pharma Signs ADC Collaboration and License Agreement with Novartis OBI Pharma says it entered a collaboration and license agreement with Novartis Pharma AG to develop next-generation antibody-drug conjugates using novel payloads and OBI’s technology suite. EQUITY | Nov 16, 2026, 08:11 AM UTC L Appirits -2026/27 forecast table shows earnings estimate changes Reuters provides a table of Appirits Inc. consolidated earnings estimates (in billions of yen) for the full year ending Jan 31, 2027 versus the latest previous period. EARNINGS | Sep 09, 2026, 06:30 AM UTC